The largest database of trusted experimental protocols

8 protocols using plasmin

1

Peptide Synthesis Reagents and Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glu- and Lys-plasminogen, plasmin, low molecular weight urokinase and single or double chain t-PA were from Enzyme Research Laboratories (South Bend, IN) or Innovative Research (Novi, MI). Activated partial thromboplastin time (aPTT; STA-PTT Automate) and prothrombin time (PT; Neoplastine CI Plus) reagents were from Diagnostica Stago (Asnières, France). S-2251 (H-D-Valyl-L-leucyl-L-lysinep-Nitroaniline dihydrochloride) was obtained from Diapharma (West Chester, OH). ε-Aminocaproic acid (ε-ACA), 4-mercaptophenylacetic acid, trifluoroacetic acid (TFA), triisopropylsilane (TIS), diisopropylcarbodiimide (DIC), 3,6-Dioxa-1,8-octane-dithiol (DODT), 4-methylpiperidine, methyl t-butyl ether (MTBE) and tris(2-carboxyethyl)phosphine hydrochloride (TCEP) were from Sigma (Saint Louis, MO). HBTU, N,N-diisopropylethylamine (DIPEA) and 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) were from Chem-Impex International (Wood Dale, IL). Fmoc-amino acid for peptide synthesis were from Midwest Biotech Inc (Fishers, IN). Dimethylformamide (DMF) and N-methylpyrrolidone (NMP) were from AGTC Bioproducts (Framingham, MA).
+ Open protocol
+ Expand
2

Antithrombin Activity of Albumin Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine if albumin fusion proteins possessed latent antithrombin activity, a two-stage assay was employed as previously described [14 (link), 19 (link)]. Briefly, albumin fusion proteins (400 nM) were combined with 300 nM purified protease in PPNE buffer (20 mM sodium phosphate, pH 7.4, 0.1% polyethylene glycol 8000, 100 mM NaCl, 0.1 mM EDTA) for varying times. Purified proteases included FXIa, Factor Xa (FXa), Factor XIIa (FXIIa), plasmin (Enzyme Research Laboratories (South Bend, IN, USA)) and recombinant FVIIa (Niastase, Novo Nordisk Canada, Mississauga, ON, Canada). First-stage reaction products were combined 1:1 with 10 nM thrombin in PPNE for 1 min, and then diluted 10-fold into 100 μM S2238 chromogenic substrate (Chromogenix, Lexington, MA, USA). Colour generation from the amidolysis reaction was followed for 5 min to determine the reaction velocity. In some reactions HEPES-buffered saline (HBS; 25 mM HEPES, pH 7.4, 100 mM NaCl) supplemented with 5 mM calcium chloride was substituted for PPNE.
+ Open protocol
+ Expand
3

Characterization of Fibrinolytic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human fibrinogen (plasminogen-, vWF-, and fibronectin-depleted), plasmin, and α-thrombin were from Enzyme Research Laboratories (South Bend, IN). The anti-His(C-term) monoclonal antibody (anti-His tag mAb) conjugated with HRP was from Invitrogen (Carlsbad, CA). The sheep anti-N-cadherin polyclonal antibodies AF6426 were purchased from R&D Systems (Minneapolis, MN). The horseradish peroxidase (HRP)-conjugated rabbit anti-sheep polyclonal antibodies and the SuperBlue Reserve TMB microwell peroxidase substrate were from SeraCare (Milfort, MA). Thrombin CleanCleave kit was obtained from Sigma (St. Louis, MO).
+ Open protocol
+ Expand
4

Cathepsin-Mediated Fibrin Degradation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Increasing amounts (0, 0.15, 0.375, 0.75, or 1.5 μg) of recombinant human cathepsins K, L, S (Enzo) in 50 μl assay buffer (0.1M sodium phosphate buffer, pH 6.0, 1mM EDTA) with 2mM dithiothreitol (DTT) for 24 hours at 37°C. Fibrin gels were alternatively incubated with plasmin (5μg/μL; Enzyme Research Laboratories) or Tris-HCl/NaCl. Plates were imaged 4, 8, and 24hrs after degradation. The samples were centrifuged at 8000 rpm and the soluble fraction as collected and saved. The insoluble fraction was prepared in 50mM Tris-HCl/100mM NaCl with 25% β-mercaptoethanol (OmniPur) and sonicated. insoluble fraction and soluble fraction samples were prepped for reduced SDS-PAGE and multiplex gelatin zymography.
+ Open protocol
+ Expand
5

Purification and Characterization of Fibrinogen D Fragment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fg (Enzyme Research Laboratories) was digested with plasmin (10 μg/15 mg of Fg) (Enzyme Research Laboratories) in TBS containing 10 mM CaCl2 for 4 h at 37°C as previously described (47 (link)) with modifications. Following plasmin digestion, Fg D fragment was obtained by column gel filtration on a Sephacryl S-200 (GE Healthcare) column with a molecular weight cutoff of 30 K, followed then by filtration in a column with a 50-K cutoff to remove plasmin. Purity of purified D fragments was analyzed by SDS-PAGE and appeared as a single band with a molecular mass of 85 kDa. Human Fg E fragment (Fg-E) was purchased from Haematologic Technologies (HCI-0150E).
+ Open protocol
+ Expand
6

Microvascular Endothelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCDB 131 (microvascular endothelial cell medium), epidermal GF, hydrocortisone, glutamine, fetal calf serum, penicillin/streptomycin, trypsin-EDTA (0.25%), and trypsin neutralizer solution were purchased from Life Technologies (Carlsbad, CA). CnT-07 epithelial proliferation medium was obtained from CellnTec Advanced Cell Systems (Bern, Switzerland). Purified human a-thrombin, g-thrombin, factor XIa, factor XIIa-a, factor XIIa-b, kallikrein, activated protein C, plasmin, factor Xa, and fibrinogen were sourced from Enzyme Research Laboratories (South Bend, IN). Human neutrophil elastase, porcine pancreatic elastase, human urokinase plasminogen (PLG) activator, human tissue-type PLG activator, and human cathepsin G were purchased from Molecular Innovations (Novi, MI). Human chymase, bovine a-chymotrypsin, porcine trypsin, bivalirudin, human antithrombin III, Glu-type human PLG, [Tyr(SO3H)]63]-Hirudin fragment 54-65, human plasma, E coli O111:B4 lipopolysaccharide, and FITC-Dextran 70,000 were procured from Sigma-Aldrich/EMD Millipore (Saint Louis, MO). A complete list of all chromogenic substrates and their suppliers is provided in Supplementary Table S1. All other chemicals were of analytical grade and were commercially available.
+ Open protocol
+ Expand
7

Coagulation Factors and DNA Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human FXII, FXIIa, PK, α-kallikrein and plasmin were from Enzyme Research Laboratory (South Bend, IN). Human factor XIa was from Haematologic Technologies (Burlington, VT). Type I fibrillar collagen was from Chrono-Log (Havertown, PA). Anhydrous iron (III) chloride (FeCl3, molecular mass 160.20 Daltons) and delipidated bovine serum albumin (BSA) was from Sigma-Aldrich. Phosphatidylcholine:phosphatidylserine (PC/PS) vesicles were form Avanti Polar Lipids (Alabaster, Alabama). S-2366 (L-pyro-Glu-L-Pro-L-Arg-p-nitroanilide) and S2302 (H-D-prolyl-L-phenylalanyl-L-arginine-p-nitroaniline dihydrochloride.) were from DiaPharma (West Chester, OH). Z-Gly-Gly-Arg-AMC was from Bachem (Torrance, CA). PTT A silica-based activated partial thromboplastin time (aPTT) reagent was from Diagnostic Stago (Parsippany, NJ). Human genomic DNA was isolated from blood leukocytes by conventional phenol:chloroform extraction.
+ Open protocol
+ Expand
8

Plasmin Concentration and Fibrin Fiber Lysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the effect of Plasmin concentration on the lysis of bead-labeled fibers, trials at varying Plasmin concentrations were conducted. Samples were made as described previously and labeled with a bead solution at 4.55x109 beads/μL concentration. After labeling, samples were visually searched using 480 nm light (corresponding to the ALEXA-488 wavelength) to find areas with individual fibers while minimally exciting the beads. The wavelength was changed to 553 nm (corresponding to the fluorescent bead excitation wavelength (580 nm)), Plasmin was added, and images were collected every 30 s for one hour. Plasmin (Enzyme Research Labs, 11.03 U/mL, stock concentration) was aliquoted and frozen (-20° C) at concentrations that were double the desired final concentration. During an experiment, one aliquot was thawed and added to the fibrin-network containing solution at equal volumes (final total volume of 20 μL), thereby halving the Plasmin concentration. Five trials were conducted at each of the following final Plasmin concentration, 0.7 U/mL, 1.0 U/mL, and 2.0 U/mL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!